1. Home
  2. Events
  3. The Agitation In Alzheimer’s Screener For Caregivers (AASC™): How Caregivers Can Use This New Screener To Recognize The Breadth Of Agitation Symptoms & Facilitate Conversations With Healthcare Professionals

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

The Agitation In Alzheimer’s Screener For Caregivers (AASC™): How Caregivers Can Use This New Screener To Recognize The Breadth Of Agitation Symptoms & Facilitate Conversations With Healthcare Professionals

As a follow-up to the previous webinar, “An Introduction to the AASCTM,” this webinar will re-ground on the current landscape of Alzheimer’s dementia (AD) and the negative impact agitation in Alzheimer’s dementia (AAD) has on both caregivers and patients. Additionally, it will introduce guidance on how caregivers should use the AASCTM to support patients. During this session, presenters will provide a didactic overview and engage in role-playing scenarios to illustrate how community caregivers can use the AASCTM to facilitate a conversation with their health care provider (HCP).

Featuring

Marc E.-Agronin

Marc E. Agronin, MD

Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine

Carrie-Shaw

Carrie Shaw, MD

CEO & Founder of Embodied Labs

Katie-Sulkowski

Katie Sulkowski, PharmD

Medical Science Liaison

Speakers Dr. Marc E. Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Katie Sulkowski, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources